RBC Capital lowered the firm’s price target on Berry Global to $74 from $78. The firm keeps an Outperform rating on the shares given solid operating performance despite demand headwinds and price/cost initiatives set to yield $140M run-rate benefits, as well as a possible catalyst from the HHS strategic review, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on BERY: